স্ট্রোকের অস্ত্রোপচারে দেশীয় যন্ত্রের ব্যবহার, সবুজ সংকেত মিলল স্বাস্থ্য মন্ত্রকের

দেশীয় যন্ত্র চালু হলে নিম্ন-মধ্যবিত্ত রোগীরা বিশেষভাবে উপকৃত হবেন । এর দাম বিদেশি যন্ত্রের তুলনায় প্রায় অর্ধেক হবে ।

Transcript

00:00This trial is called Grassroot Trial.

00:03This is the mechanical sombectomy of the stroke area.

00:08This is the case of the stroke area.

00:13This is the case of the stroke area.

00:20This is called Stent Retriever.

00:27This is the case of Stent Retriever's device.

00:33This trial has managed by itself.

00:38This is the case of the stroke area.

00:40The cost of the population is watched.

00:45This trial has been taken in place to suffer from the population.

00:54So we are very confident that at least the cost of the therapy is 50% of the reduction of the therapy.

01:03So this is the case of the trial that we have had 8 patients in New Delhi.

01:14In Eastern India, we did the CMRI.

01:18So this stroke trial has been successfully completed.

01:22and the CDSCO has already been aware that we have had a lot of stroke therapy and marketing rights.

01:36How much is the age limited?

01:40There is a trial.

01:42There is a guideline that 80% of this age group has been targeted.

01:47Therefore, there is no need to talk about age groups.

01:51For example, in Japan, there were 104 boys in Japan,

01:57and in our trials, all the boys were 22,

02:02and all the boys were 54.

02:07How many groups do you think?

02:10We are ready.